Sensus Healthcare, Inc. Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
Sensus Healthcare, Inc. (SRTS) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $100.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2025-11-12
- Sensus Healthcare, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Sensus Healthcare, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Sensus Healthcare, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2025-03-31 was $100.00K.
- Sensus Healthcare, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2024-12-31 was -$23.00K.
- Sensus Healthcare, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Sensus Healthcare, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2022 was $107.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 3 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 6 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 9 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $100.00K 10-Q · filed 2025-11-12 | $77.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $100.00K 10-Q · filed 2025-08-12 | $77.00K derived: sum of 3 quarters · filed 2025-11-12 | $158.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-15 | $77.00K derived: sum of 2 quarters · filed 2025-11-12 | $158.00K derived: sum of 3 quarters · filed 2025-11-12 | $200.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-12-31 | -$23.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-12 | $58.00K derived: sum of 2 quarters · filed 2025-11-12 | $100.00K derived: sum of 3 quarters · filed 2025-11-12 | $100.00K 10-Q · filed 2025-11-12 |
| 2024-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $123.00K derived: sum of 2 quarters · filed 2024-11-14 | $123.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $42.00K 10-Q · filed 2024-08-13 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-05 | |||
| 2022-12-31 | $107.00K 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |